The Role of a Prescription Drug Monitoring Program in Reducing Prescription Drug Diversion, Misuse, and Abuse
Provides facts about the benefits of using PDMPs for prescribers, pharmacists, patients, and regulatory and law enforcement agencies.
This collection of tools and resources is for providers, staff, and patients who offer or use services to address substance use, and other interested stakeholders. This collection was originally established following an environmental scan on implementing medication-assisted treatment (MAT) for opioid use disorder (OUD) in rural primary care. (See PDFs of Volume 1 [PDF 0.69 MB] and Volume 2 [PDF 1.28 MB] of that scan). Items have been continuously added to this collection since then, and the collection has expanded to cover substance use more broadly, rather than just MAT for OUD.
Provides facts about the benefits of using PDMPs for prescribers, pharmacists, patients, and regulatory and law enforcement agencies.
Provides an overview of prior authorization and tips to reduce the burden of prior authorizations in physician practices. It also discusses the future of prior authorizations, including remaining challenges and practice workflow adjustments, as well as advocacy regarding prior authorization at the State level.
Provides information for pregnant women about how taking methadone or buprenorphine may affect delivery, breastfeeding, and newborn infants.
Offers guidance on the use of MAT with extended-release injectable naltrexone for the treatment of OUD. Covers assessing patients, initiating MAT, monitoring progress, and deciding when to end treatment.
Includes a short video that demonstrates how to train people to use the VA Auto-Injector Naloxone Kit.